Activating HER2 mutations in HER2 gene amplification negative breast cancer

Keyphrases

• Negative Breast Cancer 100%
• HER2 mutation 100%
• HER2 Amplification 100%
• HER2 Somatic mutation 100%
• Breast Cancer 75%
• Activating mutation 75%
• Human Epidermal Growth Factor Receptor 2 (HER2) 50%
• EGF Receptor 50%
• Neratinib 50%
• HER2 Inhibitors 50%
• Phosphorylation 25%
• Breast Cancer Patients 25%
• Targeted Drugs 25%
• In Vitro Kinase Assay 25%
• Drug Target 25%
• HER3 25%
• Genome Sequencing 25%
• Tumorigenesis 25%
• Cancer Genome Sequencing 25%
• HER2-targeted Therapy 25%
• Protein Structure Analysis 25%
• Breast Cancer Treatment 25%
• Kinase Inhibitor 25%
• In-frame Deletion 25%
• Somatic mutations in Cancer 25%
• Lapatinib 25%
• Cell Culture Experiment 25%
• Exon 19 25%
• Xenograft Experiments 25%
• Lapatinib Resistance 25%

Biochemistry, Genetics and Molecular Biology

• Somatic Mutation 100%
• Gene Amplification 100%
• Kinase 50%
• Phosphotransferase 50%
• Epidermal Growth Factor Receptor 50%
• Lapatinib 50%
• Neratinib 50%
• Drive 25%
• Carcinogenesis 25%
• Exon 25%
• Protein Structure 25%
• Cell Culture 25%
• Cancer Genome Sequencing 25%
• Structure Analysis 25%

Medicine and Dentistry

• Breast Cancer 100%
• Gene Amplification 100%
• Somatic Mutation 66%
• Epidermal Growth Factor Receptor 33%
• Lapatinib 33%
• Neratinib 33%
• Cancer Therapy 16%
• Malignant Neoplasm 16%
• In Vitro 16%
• Exon 16%
• Carcinogenesis 16%
• Cell Culture 16%
• Protein Structure 16%
• Drive 16%
• Xenograft 16%
• Phosphotransferase Inhibitor 16%
• Kinase Assay 16%
• Structure Analysis 16%
• Cancer Genome Sequencing 16%